No Detail Found!

Hearing Loss and the A ecting Factors in Patients with Fibromyalgia

Author(s)
Hanife Caglar Yagci Department of Physical Medicine and Rehabilitation, Istanbul Medeniyet University, Goztepe Prof. Dr. Suleyman Yalcin City Hospital,Istanbul,Turkey
Osman Ilkay Ozdamar Department of Otorhinolaryngology-Head and Neck Surgery, Istanbul Medeniyet University, Goztepe Prof. Dr. Suleyman Yalcin City Hospital,Istanbul,Turkey
Ozlem Ertugrul Department of Audiology, Istanbul Medeniyet University, Goztepe Prof. Dr. Suleyman Yalcin City Hospital,Istanbul,Turkey
Cansu Tosyali Salman Department of Audiology, Istanbul Medeniyet University, Goztepe Prof. Dr. Suleyman Yalcin City Hospital,Istanbul,Turkey
Ilker Yagci Department of Physical Medicine and Rehabilitation, Marmara University School of Medicine,Istanbul,Turkey
Abstract
Objective: To nd the frequency of hearing loss in newly diagnosed patients with bromyalgia (FM), and the factors a ecting it. Study Design: Descriptive study. Place and Duration of the Study: Department of Physical Medicine and Rehabilitation and Department of Otorhinolaryngology Head and Neck Surgery, Istanbul Medeniyet University, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Turkey, from March 2021 to November 2022. Methodology: Patients with FM and gender/age matched controls were compared with pure-tone audiometric (PTA), and transient evoked otoacoustic emissions (TEOE) tests after standardised otorhinolaryngologic assessment The subjects were questioned for NSAID uptake and scored with ASAS-NSAID score. Results: There were 33 patients with FM and 32 healthy volunteers. Subjective tinnitus, dizziness, and hearing loss rate in the FM group were 12%, 18%, and 15%, respectively. PTA air and bone conduction studies yielded signi cant di erences between the control and FM group (p<0.05). The statistical di erence was pronounced in higher frequencies. TEOE tests showed the FM group had signi cantly lower scores when compared to the control group at 3000 Hz and 4000 Hz (p<0.05). The median ASAS-NSAID scores were 0 for the control group and 7.78 for the FM group (p <0.001). Conclusion: Patients with FM had high rate of audiometric hearing loss of the sensorineural type. The abnormalities were more prominent in the high frequencies but also present in the low frequencies.
Publication Details
Page(s) 1124-1129
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 10, Year: 2023

Request the full text from PASTIC

Keywords
Hearing loss, Audiometry, Ototoxicity, Fibromyalgia syndrome, Central sensitisation
0

Citations

0

Downloads

52

Views